Literature DB >> 8027404

Glutathione S-transferase in bone marrow metastases of disseminated neuroblastoma.

A G Hall1, A G McGuckin, A D Pearson, A R Cattan, A J Malcolm, M M Reid.   

Abstract

Antisera to each of the three main cytosolic forms of glutathione S-transferase (GST; alpha, mu, and pi) has been used to characterise GST expression by metastatic neuroblastoma in bone marrow trephine biopsies taken from 15 patients at presentation and from five of this group at relapse. There was no correlation between expression of extra-nuclear alpha or mu GST and outcome, and no consistent pattern at relapse. Seven of eight expressing nuclear pi GST at presentation died of resistant disease. Three of five cases with no detectable nuclear pi class GST remain alive and disease free. The results provide no encouragement for further investigation of alpha or mu GST in this disease but larger studies of uniformly treated patients may show whether nuclear pi GST expression at presentation indicates likely relapse.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8027404      PMCID: PMC502030          DOI: 10.1136/jcp.47.5.468

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  10 in total

1.  Expression of MDR1 and GST pi genes in 35 advanced neuroblastomas.

Authors:  J Bourhis; O Hartmann; F DeVathaire; M J Terrier-Lacombe; L Boccon-Gibod; J Lemerle; G Riou; J Bénard
Journal:  Prog Clin Biol Res       Date:  1991

Review 2.  The glutathione S-transferases: an update.

Authors:  T D Boyer
Journal:  Hepatology       Date:  1989-03       Impact factor: 17.425

3.  Purification and characterization of a pi class glutathione S-transferase from human leukaemic cells.

Authors:  A Hall; S Foster; S J Proctor; A R Cattan
Journal:  Br J Haematol       Date:  1990-12       Impact factor: 6.998

4.  Glutathione S-transferases in human liver cancer.

Authors:  P C Hayes; L May; J D Hayes; D J Harrison
Journal:  Gut       Date:  1991-12       Impact factor: 23.059

5.  Overexpression of a novel anionic glutathione transferase in multidrug-resistant human breast cancer cells.

Authors:  G Batist; A Tulpule; B K Sinha; A G Katki; C E Myers; K H Cowan
Journal:  J Biol Chem       Date:  1986-11-25       Impact factor: 5.157

6.  Expression of human mu or alpha class glutathione S-transferases in stably transfected human MCF-7 breast cancer cells: effect on cellular sensitivity to cytotoxic agents.

Authors:  A J Townsend; C P Tu; K H Cowan
Journal:  Mol Pharmacol       Date:  1992-02       Impact factor: 4.436

7.  Enhanced expression of glutathione S-transferases in colorectal carcinoma compared to non-neoplastic mucosa.

Authors:  M Moorghen; J Cairns; L M Forrester; J D Hayes; A Hall; A R Cattan; C R Wolf; A L Harris
Journal:  Carcinogenesis       Date:  1991-01       Impact factor: 4.944

8.  Immunohistochemical demonstration of glutathione S-transferases in primary human breast carcinomas.

Authors:  J Cairns; C Wright; A R Cattan; A G Hall; B J Cantwell; A L Harris; C H Horne
Journal:  J Pathol       Date:  1992-01       Impact factor: 7.996

9.  Elevation of pi class glutathione S-transferase activity in human breast cancer cells by transfection of the GST pi gene and its effect on sensitivity to toxins.

Authors:  J A Moscow; A J Townsend; K H Cowan
Journal:  Mol Pharmacol       Date:  1989-07       Impact factor: 4.436

10.  Glutathione S-transferase (placental) as a marker of transformation in the human cervix uteri: an immunohistochemical study.

Authors:  B J Randall; B Angus; R Akiba; A Hall; A R Cattan; S J Proctor; R A Jones; C H Horne
Journal:  Br J Cancer       Date:  1990-10       Impact factor: 7.640

  10 in total
  1 in total

1.  Comparative gene expression profiling of human metallothionein-3 up-regulation in neuroblastoma cells and its impact on susceptibility to cisplatin.

Authors:  Miguel Angel Merlos Rodrigo; Simona Dostalova; Hana Buchtelova; Vladislav Strmiska; Petr Michalek; Sona Krizkova; Ales Vicha; Pavla Jencova; Tomas Eckschlager; Marie Stiborova; Zbynek Heger; Vojtech Adam
Journal:  Oncotarget       Date:  2017-12-16
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.